Insulin-like growth factor-1 (IGF-1) and leucine activate pig myogenic satellite cells through mammalian target of rapamycin (mTOR) pathway

Molecular Reproduction and Development

Volumn 75, Issue 5, 2008, Pages 810-817

  Han, Bing ^a,b   Tong, Junfeng ^b   Zhu, Mei J ^b   Ma, Changwei ^a   Du, Min ^a,b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF WYOMING   (United States)

Author keywords

IGF 1; Leucine; mTOR; Myogenic satellite cell; Skeletal muscle

Indexed keywords

INITIATION FACTOR 4E BINDING PROTEIN 1; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN; S6 KINASE; SERINE; SOMATOMEDIN C; TUBURIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL LYSATE; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; MUSCLE DEVELOPMENT; MUSCLE FIBER CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SATELLITE CELL; SIGNAL TRANSDUCTION; SWINE; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT STEM CELLS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL PROLIFERATION; CELLS, CULTURED; ENZYME ACTIVATION; INSULIN-LIKE GROWTH FACTOR I; LEUCINE; MUSCLE, SKELETAL; PROTEIN BIOSYNTHESIS; PROTEIN KINASES; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; SIROLIMUS; SWINE; UP-REGULATION;

MAMMALIA; SUIDAE;

EID: 41149159335     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.20832     Document Type: Article

References (45)

1. Anthony JC, Anthony TG, Kimball SR, Jefferson LS. 2001. Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J Nutr 131:856S-860S.
2. Blanton JR, Jr., Grant AL, McFarland DC, Robinson JP, Bidwell CA. 1999. Isolation of two populations of myoblasts from porcine skeletal muscle. Muscle Nerve 22:43-50.
3. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD. 2001. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014-1019.
4. Bolster DR, Kubica N, Crozier SJ, Williamson DL, Farrell PA, Kimball SR, Jefferson LS. 2003. Immediate response of mammalian target of rapamycin (mTOR)-mediated signalling following acute resistance exercise in rat skeletal muscle. J Physiol 553:213-220.
5. Bolster DR, Jefferson LS, Kimball SR. 2004. Regulation of protein synthesis associated with skeletal muscle hypertrophy by insulin-, amino acid- and exercise-induced signalling. Proc Nutr Soc 63:351-356.
6. Browne GJ, Finn SG, Proud CG. 2004. Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J Biol Chem 279:12220-12231.
7. Bush JA, Kimball SR, O'Connor PM, Suryawan A, Orellana RA, Nguyen HV, Jefferson LS, Davis TA. 2003. Translational control of protein synthesis in muscle and liver of growth hormone-treated pigs. Endocrinology 144:1273-1283.
8. Cheng SW, Fryer LG, Carling D, Shepherd PR. 2004. Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J Biol Chem 279:15719-15722.
9. Deldicque L, Theisen D, Francaux M. 2005. Regulation of mTOR by amino acids and resistance exercise in skeletal muscle. Eur J Appl Physiol 94:1-10.
10. Doumit ME, Merkel RA. 1992. Conditions for isolation and culture of porcine myogenic satellite cells. Tissue Cell 24:253-262.
11. Du M, Zhu MJ, Means WJ, Hess BW, Ford SP. 2004. Effect of nutrient restriction on calpain and calpastatin content of skeletal muscle from cows and fetuses. J Anim Sci 82:2541-2547.
12. Du M, Shen QW, Zhu MJ, Ford SP. 2007. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase. J Anim Sci 85:919-927.
13. Erbay E, Park IH, Nuzzi PD, Schoenherr CJ, Chen J. 2003. IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. J Cell Biol 163:931-936.
14. Gaben AM, Saucier C, Bedin M, Barbu V, Mester J. 2004. Rapamycin inhibits cdk4 activation, ñ21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts. Int J Cancer 108:200-206.
15. Gao X, Zhang Y, Arrazola P, Hino O, Kobayashi T, Yeung RS, Ru B, Pan D. 2002. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol 4:699-704.
16. Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, Tokunaga C, Avruch J, Yonezawa K. 2002. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110:177-189.
17. Hardie DG. 2004. AMP-activated protein kinase: A key system mediating metabolic responses to exercise. Med Sci Sports Exerc 36:28-34.
18. Hashemolhosseini S, Nagamine Y, Morley SJ, Desrivieres S, Mercep L, Ferrari S. 1998. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J Biol Chem 273:14424-14429.
19. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, Hardie DG. 2005. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2:9-19.
20. Inoki K, Zhu T, Guan KL. 2003. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115:577-590.
21. Jakobsen SN, Hardie DG, Morrice N, Tornqvist HE. 2001. 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J Biol Chem 276:46912-46916.
22. Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, Thomas G. 1997. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J 16:3693-3704.
23. Kim DH, Sarbassov DD, Ali SM, Latek RR, Guntur KV, Erdjument-Bromage H, Tempst P, Sabatini DM. 2003. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell 11:895-904.
24. Kim J, Solis RS, Arias EB, Cartee GD. 2004. Postcontraction insulin sensitivity: Relationship with contraction protocol, glycogen concentration, and 5′ AMP-activated protein kinase phosphorylation. J Appl Physiol 96:575-583.
25. Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, Lin HC, Yancopoulos GD, Glass DJ. 2005. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280:2737-2744.
26. Lawrence JC, Jr. 2001. mTOR-dependent control of skeletal muscle protein synthesis. Int J Sport Nutr Exerc Metab 11:S177-S185.
27. Lynch CJ, Halle B, Fujii H, Vary TC, Wallin R, Damuni Z, Hutson SM. 2003. Potential role of leucine metabolism in the leucine-signaling pathway involving mTOR. Am J Physiol Endocrinol Metab 285: E854-E863.
28. Martin DE, Hall MN. 2005. The expanding TOR signaling network. Curr Opin Cell Biol 17:158-166.
29. McManus EJ, Alessi DR. 2002. TSC1-TS C2: A complex tale of PKB-mediated S6K regulation. Nat Cell Biol 4:E214-E216.
30. Nader GA, McLoughlin TJ, Esser KA. 2005. mTOR function in skeletal muscle hypertrophy: increased ribosomal RNA via cell cycle regulators. Am J Physiol Cell Physiol 289:01457-1465.
31. Ohanna M, Sobering AK, Lapointe T, Lorenzo L, Praud C, Petroulakis E, Sonenberg N, Kelly PA, Sotiropoulos A, Pende M. 2005. Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol 7:286-294.
32. Park IH, Chen J. 2005. Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotome maturation. J Biol Chem 280:32009-32017.
33. Park IH, Erbay E, Nuzzi P, Chen J. 2005. Skeletal myocyte hypertrophy requires mTOR kinase activity and S6 K1. Exp Cell Res 309:211-219.
34. Sakamoto K, Aschenbach WG, Hirshman MF, Goodyear LJ. 2003. Akt signaling in skeletal muscle: Regulation by exercise and passive stretch. Am J Physiol Endocrinol Metab 285:E1081-E1088.
35. Schmelzte T, Hall MN. 2000. TOR, a central controller of cell growth. Cell 103:253-262.
36. Shen WH, Boyle DW, Wisniowski P, Bade A, Liechty EA. 2005. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids. J Endocrinol 185:275-289.
37. Song YH, Godard M, Li Y, Richmond SR, Rosenthal N, Delafontaine P. 2005. Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation. J Investig Med 53:135-142.
38. Subramaniam S, Shahani N, Strelau J, Laliberte C, Brandt R, Kaplan D, Unsicker K. 2005. Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway. J Neurosci 25:2838-2852.
39. Suzuki K, Nakagawa M, Katoh K, Kadowaki H, Shibata T, Uchida H, Obara Y, Nishida A. 2004. Genetic correlation between serum insulin-like growth factor-1 concentration and performance and meat quality traits in Duroc pigs. J Anim Sci 82:994-999.
40. Sweatt AJ, Wood M, Suryawan A, Wallin R, Willingham MC, Hutson SM. 2004. Branched-chain amino acid catabolism: Unique segregation of pathway enzymes in organ systems and peripheral nerves. Am J Physiol Endocrinol Metab 286:E64-E76.
41. Tokunaga C, Yoshino K, Yonezawa K. 2004. mTOR integrates amino acid- and energy-sensing pathways. Biochem Biophys Res Commun 313:443-446.
42. Vary TC. 2006. IGF-I stimulates protein synthesis in skeletal muscle through multiple signaling pathways during sepsis. Am J Physiol Regul Integr Comp Physiol 290:R313-R321.
43. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M, Carling D. 2005. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2:21-33.
44. Yang X, Zhu MJ, Sreejayan N, Ren J, Du M. 2005. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway. Mol Cells 20:263-270.
45. Zhu MJ, Ford SP, Means WJ, Hess BW, Nathanielsz PW, Du M. 2006. Maternal nutrient restriction affects properties of skeletal muscle in offspring. J Physiol 575:241-250.